Growth Hormone

Ipamorelin

Follow to see evidence and UK status changes for this compound in your updates.

Nearly always taken alongside CJC-1295 to raise the body's own growth hormone. The appeal is that it's 'cleaner' than older versions, less likely to spike appetite or other hormones. Human trials for this exact use are still thin, though.

Growth-hormone with direct human PK/PD evidence, but limited evidence for meaningful wellness or body-composition outcomes.

How well studied

Tier Guide: A = Well studied, B = Some good studies, C = Early evidence & D = Barely studied

BHow well studiedSome good studies

Tested in people, but in smaller or fewer studies. A decent picture, just less certain.

UK status

How you could legitimately come across it here, if at all

UK statusNo authorised UK product

No authorised UK medicine contains this, and we have no record of a routine UK clinic route. Material sold online is unregulated.

Evidence strength and UK regulatory status answer different questions.

Overview

How it works

Targets one specific hormone switch to trigger growth hormone release, leaving the appetite and stress-hormone switches alone, unlike older versions.

Selectively stimulates the to trigger GH release, without meaningfully raising cortisol or appetite.

Reported benefits

  • Human volunteer studies show dose-related growth-hormone release
  • Clinical benefits for recovery, sleep, muscle gain or fat loss are not established

Who it's typically used for

Research interest in growth-hormone secretagogue pharmacology; not an established treatment for recovery, sleep or body composition.

Timeline to results

Human studies establish an acute growth-hormone response, not a validated timeline for recovery or body-composition outcomes.

Safety & UK access

Dosage

No established human dose

No established self-administration dose: limited controlled human trials for this specific use.

Side effects

  • Injection site reactionsreported
  • Headachereported in the early intravenous dose-escalation study in healthy men
  • Raised growth hormone and IGF-1expected pharmacological effect; long-term consequences unknown

Getting it in the UK

UK statusNo authorised UK product

No authorised UK medicine contains this, and we have no record of a routine UK clinic route. Material sold online is unregulated.

Where it turns up

  • Not routinely available in the UK
  • Unregulated online market

No authorised UK medicinal product containing ipamorelin was identified in this audit. EviTide does not treat online or clinic marketing as proof of a lawful UK supply route.

Not MHRA-licensed; prescribable by a private UK doctor via the unlicensed-medicines route

MHRA: the UK regulator that assesses whether a medicine is safe and works before it can be authorised for use here. Something not being MHRA-licensed does not automatically mean it is illegal, and it does not mean it is safe.

This is background information about UK regulation, not advice about what you can or should obtain.

Evidence & sources

Why this rating?

The A to D rating shown above comes from our earlier editorial review and is still waiting to be migrated into the structured review record below. That is a gap in our record-keeping, not a sign the rating is wrong.

Evidence fingerprint

No route and indication scope has been published for this profile yet, so no fingerprint is shown.

Sources

Structured source audit not yet published for this profile. The references behind this page are being catalogued one compound at a time, and this one has not been through that process yet.

Content freshness

Last reviewed
24 Sept 2026
Regulatory status last checked
21 Aug 2026